Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View compact data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View compact data table
Study IDStudyExperiment NameExperiment NotesStrain Ont IDStrainSexAge# of AnimalsSample NotesClinical Measurement Ont IDPhenotypeFormulaClinical Measurement NotesAverage TypeValueUnitsSEMSDMethod Ont IDMethodMethod SiteMethod DurationMethod NotesPost Insult TypePost Insult Time ValuePost Insult Time UnitConditionsRecord IDCondition 1aCondition 1b
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.body massRS:0000228DA.PVG.1AV1-(D4Rat155-Spr)both200 days to 120 days14CMO:0001400maximum body weight loss to initial body weight ratio12.5%0.93.3675MMO:0000016body weighing method0.0type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69800type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.body massRS:0000228DA.PVG.1AV1-(D4Rat155-Spr)both200 days to 120 days24CMO:0001400maximum body weight loss to initial body weight ratio10.6%1.15.3889MMO:0000016body weighing method0.0pristane (150 ul) 69806pristane (150 ul)
1301Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96.joint integrity traitRS:0000228DA.PVG.1AV1-(D4Rat155-Spr)both0 days12CMO:0001453percentage of study population developing experimental arthritis during a period of time25%MMO:0000163in vivo visual assessment0.0Freund's incomplete adjuvant (200 ul) 70197Freund's incomplete adjuvant (200 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000228DA.PVG.1AV1-(D4Rat155-Spr)both200 days to 120 days24CMO:0001453percentage of study population developing experimental arthritis during a period of time100%MMO:0000163in vivo visual assessment0.0pristane (150 ul) 69719pristane (150 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000228DA.PVG.1AV1-(D4Rat155-Spr)both200 days to 120 days14CMO:0001453percentage of study population developing experimental arthritis during a period of time100%MMO:0000163in vivo visual assessment0.0type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69712type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
1301Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96.joint integrity traitRS:0000228DA.PVG.1AV1-(D4Rat155-Spr)both0 days12CMO:0001450post-insult time to onset of experimental arthritis13.7d0.4331.5MMO:0000163in vivo visual assessment0.0Freund's incomplete adjuvant (200 ul) 70198Freund's incomplete adjuvant (200 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000228DA.PVG.1AV1-(D4Rat155-Spr)both200 days to 120 days14CMO:0001450post-insult time to onset of experimental arthritis14.3d0.31.1225MMO:0000163in vivo visual assessment0.0type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69780type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000228DA.PVG.1AV1-(D4Rat155-Spr)both200 days to 120 days24CMO:0001450post-insult time to onset of experimental arthritis12.5d0.52.4495MMO:0000163in vivo visual assessment0.0pristane (150 ul) 69787pristane (150 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.orosomucoid 1 amountblood alpha-1-acid glycoprotein amountRS:0000228DA.PVG.1AV1-(D4Rat155-Spr)both180 days to 120 days14CMO:0001466serum orosomucoid 1 level660mg/lMMO:0000439radial immunodiffusion assay0.0radial immunodiffusion assaytype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69759type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.orosomucoid 1 amountblood alpha-1-acid glycoprotein amountRS:0000228DA.PVG.1AV1-(D4Rat155-Spr)both180 days to 120 days24CMO:0001466serum orosomucoid 1 level1060mg/lMMO:0000439radial immunodiffusion assay0.0radial immunodiffusion assaypristane (150 ul) 69766pristane (150 ul)